About Sinopharm Group
Sinopharm Group is a company based in Shanghai (China) founded in 2003. The company has 61,694 employees. Sinopharm Group offers products and services including Drug Distribution and Medical Devices.
- Headquarter Shanghai, China
- Employees 61,694
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website sinopharmgroup.com.cn
- Legal Name Sinopharm Group Co., Ltd. Class H
- Annual Revenue$80.13 B (USD)-1.57as on Dec 31, 2025
- Net Profit$996.89 M (USD)1.52as on Dec 31, 2025
- EBITDA$2.92 B (USD)-4.79as on Dec 31, 2025
- Employee Count61,694
Associated legal entities of Sinopharm Group
Sinopharm Group operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Sinopharm Group
Sinopharm Group offers a comprehensive portfolio of products and services, including Drug Distribution and Medical Devices.
Drug distribution is conducted by Sinopharm Group to manage the supply of pharmaceuticals across various channels.
Medical devices are manufactured and distributed by Sinopharm Group to support healthcare applications.
People of Sinopharm Group
22 people are tracked at Sinopharm Group (6 in leadership, 15 in board & advisors, 1 in team); the tracked headcount is 61,694.
| Name | Role | Group |
|---|---|---|
Liu Yong | Executive Director, President | Leadership |
Cai Maisong | Vice President | Leadership |
Li Yang | Vice President | Leadership |
Jiang Xiuchang | Vice President | Leadership |
Li Xiaojuan | CFO | Leadership |
Chen Zhanyu | Vice President | Leadership |
Li Zhiming | Executive Director, Chairman | Board & advisors |
Wu Tak Lung | Independent Non-executive Director | Board & advisors |
Chen Fangruo | Independent non-executive Director | Board & advisors |
Wen Deyong | Non-Executive Director | Board & advisors |
Ma Ping | Non-Executive Director | Board & advisors |
Deng Jindong | Non-Executive Director | Board & advisors |
Zhuo Fumin | Independent Non-Executive Director | Board & advisors |
Li Peiyu | Independent non-executive Director | Board & advisors |
Chen Qiyu | Non-Executive Director & Vice Chairman | Board & advisors |
Feng Rongli | Non-Executive Director | Board & advisors |
Hu Jianwei | Non-Executive Director | Board & advisors |
Li Dongjiu | Non-Executive Director | Board & advisors |
Yu Qingming | Chairman | Board & advisors |
Yu Weifeng | Independent Non-Executive Director | Board & advisors |
2 more people are available in the full profile.
Complete people profiles for Sinopharm Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Sinopharm Group
Sinopharm Group is a publicly listed company on the HKEX with ticker symbol 1099 in Hong Kong, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Sep 2009
- Listed onHKG: 1099
- Listed entitySinopharm Group Co., Ltd. Class H
- Exchange sectorDistribution services
- ISINCNE100000FN7
- Share price14.80 HKD (-0.47% on the day) · 2026-10-12
- Market capitalisation46,404,151,255.00 HKD
- Price to earnings5.8
- EPS (diluted, trailing year)2.54 HKD
- Dividend yield5.31%
- Volume (last session)4,631,847
Financials of Sinopharm Group
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 623.78B HKD | 7.76B HKD | 22.74B HKD |
| 2024 | 633.74B HKD | 7.64B HKD | 23.89B HKD |
| 2023 | 659.21B HKD | 10.00B HKD | 28.90B HKD |
| 2022 | 642.08B HKD | 9.91B HKD | 30.33B HKD |
| 2021 | 627.98B HKD | 9.35B HKD | 29.20B HKD |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Sinopharm Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Sinopharm Group
The website of Sinopharm Group (sinopharmgroup.com.cn) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 18.9% vs previous month
Similar companies to Sinopharm Group
10 companies that operate in the same segment as Sinopharm Group (Medical Device Tech & Outsourcing), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 | |
Home medical and respiratory equipment and supplies are distributed. | 2005 | Phoenixville, Pennsylvania, United States | USD 4 M | USD 3.24 B | 10,500 | |
Cybersecurity solutions for medical devices are provided by MedCrypt. | 2016 | San Diego, California, United States | USD 63.75 M | – | – | |
Laboratory and production supplies and services are provided. | 1902 | Hampton, Virginia, United States | – | – | 592 | |
Life science products and services are supplied to researchers worldwide. | 1852 | Radnor, Pennsylvania, United States | USD 2 M | USD 4.38 B | 1,657 | |
Manufacturer of surgical lights, operating tables, and anesthesia machine | 1989 | Getinge, Halland, Sweden | – | USD 3.8 B | – | |
Medical device components are developed and manufactured for healthcare markets. | 1970 | Frisco, Texas, United States | – | USD 1.85 B | 11,000 | |
Wholesaler & distributor of healthcare, medical, and pharmaceutical products | 1922 | Docklands, Victoria, Australia | – | USD 8.84 B | 5,700 | |
Reprocessor of single-use medical devices for cardiology procedures | 2013 | Scottsdale, Arizona, United States | USD 18 M | – | 143 | |
Provider of global contract manufacturing services | 1973 | Parma, Emilia-romagna, Italy | USD 26.41 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sinopharm Group
Sinopharm Group was founded in 2003.
Sinopharm Group is headquartered in Shanghai, China.
Sinopharm Group has 61,694 employees.
Annual revenue of Sinopharm Group is $80.13B as on Dec 31, 2025.
Sinopharm Group was established in 2003 and is headquartered in Shanghai, China. Operations focus on the distribution of pharmaceutical products and medical equipment within the healthcare sector. Services encompass supply chain management and logistics for medicines and devices. In 2022, annual revenues of 81.97 billion were achieved, alongside a net profit of 1.26 billion, supporting its role in Chinas pharmaceutical market.
Sinopharm Group offers Drug Distribution and Medical Devices.
Yes, Sinopharm Group is publicly traded on HKEX under the ticker symbol 1099.
Sinopharm Group operates through ,.